The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Lumen Bioscience, Inc., Arzeda, Riffyn Among the most popular fund investment industries, there are Life Science, Medical Device. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Bioeconomy Capital, startups are often financed by UK Innovation & Science Seed Fund, Sofinnova Partners, Oreilly AlphaTech Ventures. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Oreilly AlphaTech Ventures, Sofinnova Partners. In the next rounds fund is usually obtained by SOSV, Oreilly AlphaTech Ventures, UK Innovation & Science Seed Fund.
Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
|4M||01 Aug 2017||United States, Oakland|
|3M||11 Feb 2015||United Kingdom, Westminster|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.